FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LONGONI, B.
Right arrow Articles by MOSCA, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LONGONI, B.
Right arrow Articles by MOSCA, F.
(The FASEB Journal. 2001;15:731-740.)
© 2001 FASEB

Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels

BIANCAMARIA LONGONI*,{dagger}1, ELENA BOSCHI*, GIAN CARLO DEMONTIS{ddagger}, GIAN MICHELE RATTO§ and FRANCO MOSCA*

Departments of
* Oncology, Transplants and Advanced Technologies in Medicine,
{dagger} Physiology and Biochemistry,
{ddagger} Psychiatry and Neurobiology, University of Pisa, School of Medicine; and
§ Institute for Neurophysiology, CNR, Pisa, Italy

1Correspondence: Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Paradisa 2, I-56124 Pisa, Italy. E-mail: biancam{at}dfb.unipi.it

Treatment of transplanted patients with cyclosporin A (CSA) may cause adverse effects such as nephrotoxicity and hypertension. As CSA is known to induce oxidative stress in several tissues, it may cause vascular problems by triggering oxidative stress in endothelial cells (EC). However, oxidative stress has been reported for acute exposure to CSA concentrations exceeding its clinical range, whereas immunosuppression requires life-long treatment with therapeutic concentrations. We therefore compared the effects of 21 h pharmacological (200 µM) vs. 8 days clinical (0.5–2.5 µM) doses of CSA on cultured human EC. Pharmacological doses of CSA cause a decrease in cell density via apoptosis and a down-regulation of the antiapoptotic protein Bcl-2. However, these effects are independent of CSA-induced oxidative stress. In contrast, therapeutic concentrations of CSA cause Bcl-2 up-regulation and modification of EC morphology, both effects blocked by antioxidants. Therefore, a low level of oxidants may act in EC as second messengers that up-regulate Bcl-2, thus promoting survival of impaired EC. Our data suggest that the oxidative stress induced by clinical concentrations of CSA may be involved in the adverse effects of the drug on the vascular system of transplanted patients via an adaptive response involving Bcl-2 up-regulation rather than an apoptotic process.—Longoni, B., Boschi, E., Demontis, G. C., Ratto, G. M., Mosca, F. Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels.


Key Words: confocal microscopy • reactive oxygen species • antioxidants • dihydrorhodamine 123 • melatonin • transplantation




This article has been cited by other articles:


Home page
CJASNHome page
M. Naesens, D. R. J. Kuypers, and M. Sarwal
Calcineurin Inhibitor Nephrotoxicity
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 481 - 508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Kondo, Y. Tang, E. A. Scheef, N. Sheibani, and C. M. Sorenson
Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1521 - C1530.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Tomasiak, T. Rusak, M. Gacko, and H. Stelmach
Cyclosporine enhances platelet procoagulant activity
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1750 - 1756.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S.-Y. Sun, N. Hail Jr, and R. Lotan
Apoptosis as a Novel Target for Cancer Chemoprevention
J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Chen, J. Guo, M. Yang, C. Han, M. Zhang, W. Chen, Q. Liu, J. Wang, and X. Cao
Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression
Blood, January 15, 2004; 103(2): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Carnevali, S. Petruzzelli, B. Longoni, R. Vanacore, R. Barale, M. Cipollini, F. Scatena, P. Paggiaro, A. Celi, and C. Giuntini
Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L955 - L963.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. C. Santos, J. M. Pullman, A. Chevaile, W. J. Welch, and S. R. Gullans
Chronic hyperosmolarity mediates constitutive expression of molecular chaperones and resistance to injury
Am J Physiol Renal Physiol, March 1, 2003; 284(3): F564 - F574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Schneider, F. Oswald, C. Wahl, F. R. Greten, G. Adler, and R. M. Schmid
Cyclosporine Inhibits Growth through the Activating Transcription Factor/cAMP-responsive Element-binding Protein Binding Site in the Cyclin D1 Promoter
J. Biol. Chem., November 8, 2002; 277(46): 43599 - 43607.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. V. Alvarez-Arroyo, S. Yague, R. M. Wenger, D. S. Pereira, S. Jimenez, F. R. Gonzalez-Pacheco, M. A. Castilla, J. J. P. Deudero, and C. Caramelo
Cyclophilin-Mediated Pathways in the Effect of Cyclosporin A on Endothelial Cells: Role of Vascular Endothelial Growth Factor
Circ. Res., August 9, 2002; 91(3): 202 - 209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The Federation of American Societies for Experimental Biology.